Description  Claims  Drawing  Cited references 

US7579318B   [0033] 
US7514530B   [0033] 
WO2007069090A2   [0103] 
WO2008036929A2   [0103] 
WO2011051435W   [0104] 

Methods in Enzymology   [0017] 
Towards safe, non-viral therapeutic gene expression in humans   [0103] 
Knocking down barriers: advances in siRNA delivery   [0103] 
Handbook of Cell-Penetrating Peptides   [0103] 
Twenty years of cell-penetrating peptides : from molecular mechanisms to therapeutics   [0103] 
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy   [0103] 
Cell-penetrating peptides: tools for intracellular delivery of therapeutics   [0103] 
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells   [0103] 
A peptide carrier for the delivery of biologically active proteins into mammalian cells   [0103] 
Prediction of peptide structure: how far are we?   [0103] 
Disulfide bond as peptide-resin linkage in Boc-Bzl SPPS, for potential biochemical applications   [0103] 
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth   [0103] 
A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells   [0103] 
Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation   [0103] 
A microRNA component of the p53 tumour suppressor network   [0103] 
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells   [0103] 
Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain   [0103] 
Stapled peptides for intracellular drug targets   [0103] 
Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin methathesis   [0103]